![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Influenza |
Free Subscription
1 Am J Med |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Influenza is free of charge.
COVID-19 and Light Chain Amyloidosis, Adding Insult to Injury.
Am J Med. 2022;135 Suppl 1:S49-S52.
PubMed
Abstract available
Web Exclusive. Annals On Call - Evidence-Based Care of Substance Use Disorders.
Ann Intern Med. 2022;175:OC1.
PubMed
Web Exclusive. Annals for Hospitalists Inpatient Notes - COVID-19, Hospital
Medicine, and a Way Forward.
Ann Intern Med. 2022;175:HO2-HO3.
PubMed
Moderna COVID-19 vaccine was linked to myocarditis or myopericarditis at 28 d
(4.2 events/100 000 persons).
Ann Intern Med. 2022 May 3. doi: 10.7326/J22-0021.
PubMed
Abstract available
In high-risk outpatients with COVID-19, remdesivir reduced COVID-19-related
hospitalization or all-cause death at 28 d.
Ann Intern Med. 2022 May 3. doi: 10.7326/J22-0026.
PubMed
Abstract available
In adults hospitalized with COVID-19, adding remdesivir to standard care did not
reduce in-hospital mortality.
Ann Intern Med. 2022 May 3. doi: 10.7326/J22-0025.
PubMed
Abstract available
In adults who had not had COVID-19, Novavax vaccine had 90% efficacy at >/=7 d
after the second dose.
Ann Intern Med. 2022 May 3. doi: 10.7326/J22-0028.
PubMed
Abstract available
Annals On Call - Type 1 Diabetes Mellitus in Adults.
Ann Intern Med. 2022 May 3:OC1. doi: 10.7326/A21-0010.
PubMed
Update Alert 7: Masks for Prevention of Respiratory Virus Infections, Including
SARS-CoV-2, in Health Care and Community Settings.
Ann Intern Med. 2022 Mar 29. doi: 10.7326/L21-0783.
PubMed
Summary for Patients: PCR Testing Versus Rapid Antigen Testing at a Community
Site During a COVID-19 Omicron Surge.
Ann Intern Med. 2022 Mar 15. doi: 10.7326/P22-0002.
PubMed
Comparison of SARS-CoV-2 Reverse Transcriptase Polymerase Chain Reaction and
BinaxNOW Rapid Antigen Tests at a Community Site During an Omicron Surge : A
Cross-Sectional Study.
Ann Intern Med. 2022 Mar 15. doi: 10.7326/M22-0202.
PubMed
Abstract available
Toward Unbiased Evaluation of Postacute Sequelae of SARS-CoV-2 Infection:
Challenges and Solutions for the Long Haul Ahead.
Ann Intern Med. 2022 Mar 8. doi: 10.7326/M21-4664.
PubMed
Prescribing Nirmatrelvir-Ritonavir: How to Recognize and Manage Drug-Drug
Interactions.
Ann Intern Med. 2022 Mar 1. doi: 10.7326/M22-0281.
PubMed
Major Update 2: Remdesivir for Adults With COVID-19: A Living Systematic Review
and Meta-analysis for the American College of Physicians Practice Points.
Ann Intern Med. 2022 Mar 1. doi: 10.7326/M21-4784.
PubMed
Abstract available
Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid,
Living Practice Points From the American College of Physicians (Version 2, Update
Alert 3).
Ann Intern Med. 2022 Mar 1. doi: 10.7326/M21-4810.
PubMed
The Incidence of SARS-CoV-2 Reinfection in Persons With Naturally Acquired
Immunity With and Without Subsequent Receipt of a Single Dose of BNT162b2 Vaccine
: A Retrospective Cohort Study.
Ann Intern Med. 2022 Feb 15. doi: 10.7326/M21-4130.
PubMed
Abstract available
HIV protease inhibitors Nelfinavir and Lopinavir/Ritonavir markedly improve lung
pathology in SARS-CoV-2-infected Syrian hamsters despite lack of an antiviral
effect.
Antiviral Res. 2022;202:105311.
PubMed
Abstract available
Are vaccines a potential treatment for long covid?
BMJ. 2022;377:o988.
PubMed
Trajectory of long covid symptoms after covid-19 vaccination: community based
cohort study.
BMJ. 2022;377:e069676.
PubMed
Abstract available
Covid-19: North Korean leader blames his party's incompetence after 393 000 cases
of fever reported in a day.
BMJ. 2022;377:o1228.
PubMed
Calling time on the use of war metaphors in covid-19.
BMJ. 2022;377:o1214.
PubMed
Covid-19: WHO chief calls for a shift in China's "unsustainable" policy.
BMJ. 2022;377:o1199.
PubMed
Unresolving fever, headache, cough, and negative covid-19 PCR result.
BMJ. 2022;377:e068645.
PubMed
Covid-19: Fourth dose of mRNA vaccines is safe and boosts immunity, study finds.
BMJ. 2022;377:o1170.
PubMed
Agreement of treatment effects from observational studies and randomized
controlled trials evaluating hydroxychloroquine, lopinavir-ritonavir, or
dexamethasone for covid-19: meta-epidemiological study.
BMJ. 2022;377:e069400.
PubMed
Abstract available
Circular RNA vaccines against SARS-CoV-2 and emerging variants.
Cell. 2022 Apr 1. pii: S0092-8674(22)00394-4. doi: 10.1016/j.cell.2022.
PubMed
Abstract available
Validation of Artificial Intelligence to Support the Automatic Coding of Patient
Adverse Drug Reaction Reports, Using Nationwide Pharmacovigilance Data.
Drug Saf. 2022;45:535-548.
PubMed
Abstract available
COVID-19 prevalence and mortality in longer-term care facilities.
Eur J Epidemiol. 2022;37:227-234.
PubMed
Abstract available
Infection fatality rate of COVID-19 in community-dwelling elderly populations.
Eur J Epidemiol. 2022;37:235-249.
PubMed
Abstract available
Evaluation of a Rapid and Accessible Reverse Transcription-Quantitative PCR
Approach for SARS-CoV-2 Variant of Concern Identification.
J Clin Microbiol. 2022;60:e0017822.
PubMed
Abstract available
Limit of Detection for Rapid Antigen Testing of the SARS-CoV-2 Omicron and Delta
Variants of Concern Using Live-Virus Culture.
J Clin Microbiol. 2022;60:e0014022.
PubMed
Multicenter Evaluation of the BioFire Respiratory Panel 2.1 (RP2.1) for Detection
of SARS-CoV-2 in Nasopharyngeal Swab Samples.
J Clin Microbiol. 2022;60:e0006622.
PubMed
Abstract available
Comparing population-level mental health of UK workers before and during the
COVID-19 pandemic: a longitudinal study using Understanding Society.
J Epidemiol Community Health. 2022;76:527-536.
PubMed
Abstract available
Impact of COVID-19 pandemic on the workforce: from psychological distress to the
Great Resignation.
J Epidemiol Community Health. 2022;76:525-526.
PubMed
COVID-19 infection and outcomes in a population-based cohort of 17 203 adults
with intellectual disabilities compared with the general population.
J Epidemiol Community Health. 2022;76:550-555.
PubMed
Abstract available
Occupational health, frontline workers and COVID-19 lockdown: new gender-related
inequalities?
J Epidemiol Community Health. 2022;76:537-543.
PubMed
Abstract available
Social capital and geographical variation in the incidence of COVID-19: an
ecological study.
J Epidemiol Community Health. 2022;76:544-549.
PubMed
Abstract available
How infodemic intoxicates public health surveillance: from a big to a slow data
culture.
J Epidemiol Community Health. 2022;76:623-625.
PubMed
Dietary Cholesterol Causes Inflammatory Imbalance and Exacerbates Morbidity in
Mice Infected with Influenza A Virus.
J Immunol. 2022;208:2523-2539.
PubMed
Abstract available
Cutting Edge: SARS-CoV-2 Infection Induces Robust Germinal Center Activity in the
Human Tonsil.
J Immunol. 2022;208:2267-2271.
PubMed
Abstract available
A child with acute respiratory distress syndrome caused by avian influenza H3N8
virus.
J Infect. 2022 May 13. pii: S0163-4453(22)00288.
PubMed
Induction of NK cell-mediated antibody-dependent cellular cytotoxicity (ADCC)
against SARS-CoV-2 after natural infection is more potent than after vaccination.
J Infect Dis. 2022 Mar 22. pii: 6552258. doi: 10.1093.
PubMed
Abstract available
Antibodies: A Double Leg Takedown Against COVID-19.
J Infect Dis. 2022;225:1685-1687.
PubMed
CCL5 rs2107538 Variant Is Associated With Protection Against SARS-CoV-2 Infection
and Related Mortality: A Population-Based Study.
J Infect Dis. 2022;225:1865-1866.
PubMed
Reply to Pati et al.
J Infect Dis. 2022;225:1866-1868.
PubMed
Immunogenicity and Safety of a Three-Dose Regimen of a SARS-CoV-2 Inactivated
Vaccine in Adults: A Randomized, Double-blind, Placebo-controlled Phase 2 Trial.
J Infect Dis. 2021 Dec 27. pii: 6484920. doi: 10.1093.
PubMed
Abstract available
Effectiveness of mRNA vaccines in preventing COVID-19 hospitalization by age and
burden of chronic medical conditions among immunocompetent US adults,
March-August 2021.
J Infect Dis. 2021 Dec 21. pii: 6472998. doi: 10.1093.
PubMed
Abstract available
Prevention of COVID-19 among older adults receiving pneumococcal conjugate
vaccine suggests interactions between Streptococcus pneumoniae and SARS-CoV-2 in
the respiratory tract.
J Infect Dis. 2021 Mar 9. pii: 6164926. doi: 10.1093.
PubMed
Abstract available
Pathobiology of an NS1-Truncated H3N2 Swine Influenza Virus Strain in Pigs.
J Virol. 2022 May 12:e0051922. doi: 10.1128/jvi.00519.
PubMed
Abstract available
Single-Cell Landscape of Lungs Reveals Key Role of Neutrophil-Mediated
Immunopathology during Lethal SARS-CoV-2 Infection.
J Virol. 2022 Apr 14:e0003822. doi: 10.1128/jvi.00038.
PubMed
Abstract available
Single Immunization with Recombinant ACAM2000 Vaccinia Viruses Expressing the
Spike and the Nucleocapsid Proteins Protects Hamsters against SARS-CoV-2-Caused
Clinical Disease.
J Virol. 2022 Apr 12:e0038922. doi: 10.1128/jvi.00389.
PubMed
Abstract available
First Breathalyzer Test to Diagnose COVID-19.
JAMA. 2022;327:1860.
PubMed
Rapid Antigen Tests for SARS-CoV-2.
JAMA. 2022;327:1925-1926.
PubMed
Rapid Antigen Tests for SARS-CoV-2-Reply.
JAMA. 2022;327:1926.
PubMed
Firearm Homicide and Suicide During the COVID-19 Pandemic: Implications for
Clinicians and Health Care Systems.
JAMA. 2022 May 10. pii: 2792080. doi: 10.1001/jama.2022.6924.
PubMed
Four Vaccine Doses Prevented Severe Omicron COVID-19 Better Than 3.
JAMA. 2022;327:1748.
PubMed
Two mRNA COVID-19 Vaccines Stimulate Different Immune Responses.
JAMA. 2022;327:1748.
PubMed
COVID-19 and Lessons to Improve Preparedness for the Next Pandemic.
JAMA. 2022;327:1822-1823.
PubMed
Testing, Surveillance, and Mitigation Strategies for COVID-19.
JAMA. 2022;327:1824-1825.
PubMed
Strategy for the "New Normal" of Life With COVID.
JAMA. 2022;327:1823-1824.
PubMed
COVID-19 and Lessons to Improve Preparedness for the Next Pandemic-Reply.
JAMA. 2022;327:1823.
PubMed
Testing, Surveillance, and Mitigation Strategies for COVID-19-Reply.
JAMA. 2022;327:1825.
PubMed
Strategy for the "New Normal" of Life With COVID-Reply.
JAMA. 2022;327:1824.
PubMed
mRNA Booster Improves a COVID-19 Vaccine's Effectiveness.
JAMA. 2022;327:1749.
PubMed
COVID-19 Vaccination-Becoming Part of the New Normal.
JAMA. 2022 May 2. pii: 2792030. doi: 10.1001/jama.2022.7469.
PubMed
The Pandemic Determinants of Health.
JAMA. 2022;327:1869.
PubMed
The COVID-19 Pandemic Rages on for People Who Are Immunocompromised.
JAMA. 2022 Apr 27. pii: 2791868. doi: 10.1001/jama.2022.7281.
PubMed
Stagnant US Mammography Rates and the Influence of COVID-19.
JAMA. 2022 Apr 20. pii: 2791573. doi: 10.1001/jama.2022.4295.
PubMed
Association Between SARS-CoV-2 Viral Load in Wastewater and Reported Cases,
Hospitalizations, and Vaccinations in Milan, March 2020 to November 2021.
JAMA. 2022 Apr 1. pii: 2790911. doi: 10.1001/jama.2022.4908.
PubMed
Zero COVID in China: what next?
Lancet. 2022;399:1856-1857.
PubMed
Strengthening public mental health during and after the acute phase of the
COVID-19 pandemic.
Lancet. 2022 Mar 24. pii: S0140-6736(22)00523.
PubMed
Vital Signs: Changes in Firearm Homicide and Suicide Rates - United States,
2019-2020.
MMWR Morb Mortal Wkly Rep. 2022;71:656-663.
PubMed
Abstract available
Audio Interview: What to Make of Covid-19 Hot Spots.
N Engl J Med. 2022;386:e63.
PubMed
Audio Interview: Forecasting the Future of Covid.
N Engl J Med. 2022;386:e58.
PubMed
Intrinsic Severity of the SARS-CoV-2 Omicron Variant. Reply.
N Engl J Med. 2022 Apr 20. pii: 10.1056/NEJMc2203679.
PubMed
Intrinsic Severity of the SARS-CoV-2 Omicron Variant.
N Engl J Med. 2022 Apr 20. pii: 10.1056/NEJMc2203679.
PubMed
Protection with a Third Dose of mRNA Vaccine against SARS-CoV-2 Variants in
Frontline Workers.
N Engl J Med. 2022 Apr 6. doi: 10.1056/NEJMc2201821.
PubMed
Pulse Oximetry for Monitoring Patients with Covid-19 at Home - A Pragmatic,
Randomized Trial.
N Engl J Med. 2022 Apr 6. doi: 10.1056/NEJMc2201541.
PubMed
BNT162b2 Protection against the Omicron Variant in Children and Adolescents.
N Engl J Med. 2022 Mar 30. doi: 10.1056/NEJMoa2202826.
PubMed
Abstract available
Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine.
N Engl J Med. 2022 Mar 23. doi: 10.1056/NEJMoa2200674.
PubMed
Abstract available
Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar.
N Engl J Med. 2022 Mar 9. doi: 10.1056/NEJMoa2200797.
PubMed
Abstract available
phastSim: Efficient simulation of sequence evolution for pandemic-scale datasets.
PLoS Comput Biol. 2022;18:e1010056.
PubMed
Abstract available
Phylogenetic inference of changes in amino acid propensities with single-position
resolution.
PLoS Comput Biol. 2022;18:e1009878.
PubMed
Abstract available
Abnormal global alternative RNA splicing in COVID-19 patients.
PLoS Genet. 2022;18:e1010137.
PubMed
Abstract available
Antibody responses against SARS-CoV-2 variants induced by four different
SARS-CoV-2 vaccines in health care workers in the Netherlands: A prospective
cohort study.
PLoS Med. 2022;19:e1003991.
PubMed
Abstract available
COVID-19 epidemiology and changes in health service utilization in Azraq and
Zaatari refugee camps in Jordan: A retrospective cohort study.
PLoS Med. 2022;19:e1003993.
PubMed
Abstract available
Hispanic ethnicity and mortality among critically ill patients with COVID-19.
PLoS One. 2022;17:e0268022.
PubMed
Abstract available
Telephone-based support for physical activity: Results and lessons learned during
the COVID-19 pandemic.
PLoS One. 2022;17:e0268429.
PubMed
Abstract available
Inflammation, underweight, malignancy and a marked catabolic state as predictors
for worse outcomes in COVID-19 patients with moderate-to-severe disease admitted
to Internal Medicine Unit.
PLoS One. 2022;17:e0268432.
PubMed
Abstract available
COVID-19 vaccine acceptance among health care workers in Africa: A systematic
review and meta-analysis.
PLoS One. 2022;17:e0268711.
PubMed
Abstract available
Exploring the beliefs, experiences and impacts of HIV-related self-stigma amongst
adolescents and young adults living with HIV in Harare, Zimbabwe: A qualitative
study.
PLoS One. 2022;17:e0268498.
PubMed
Abstract available
COVID-19 heterogeneity in islands chain environment.
PLoS One. 2022;17:e0263866.
PubMed
Abstract available
A retrospective observational insight into COVID-19 exposures resulting from
personal protective equipment (PPE) breaches.
PLoS One. 2022;17:e0268582.
PubMed
Abstract available
Estimation of the basic reproduction number of Alpha and Delta variants of
COVID-19 pandemic in Iran.
PLoS One. 2022;17:e0265489.
PubMed
Abstract available
A spatial-temporal analysis at the early stages of the COVID-19 pandemic and its
determinants: The case of Recife neighborhoods, Brazil.
PLoS One. 2022;17:e0268538.
PubMed
Abstract available
Health disparities and COVID-19: A retrospective study examining individual and
community factors causing disproportionate COVID-19 outcomes in Cook County,
Illinois.
PLoS One. 2022;17:e0268317.
PubMed
Abstract available
Association between history of HBV vaccine response and anti-SARS-CoV-2 spike
antibody response to the BioNTech/Pfizer's BNT162b2 mRNA SARS-CoV-2 vaccine among
healthcare workers in Japan: A prospective observational study.
PLoS One. 2022;17:e0268529.
PubMed
Abstract available
A national study of moral distress among U.S. internal medicine physicians during
the COVID-19 pandemic.
PLoS One. 2022;17:e0268375.
PubMed
Abstract available
Access to and challenges in water, sanitation, and hygiene in healthcare
facilities during the early phase of the COVID-19 pandemic in Ethiopia: A
mixed-methods evaluation.
PLoS One. 2022;17:e0268272.
PubMed
Abstract available
Dealing with inconclusive SARS-CoV-2 PCR samples-Our experience.
PLoS One. 2022;17:e0268187.
PubMed
Abstract available
Women's health status before and during the COVID-19 pandemic in rural
Bangladesh: A prospective longitudinal study.
PLoS One. 2022;17:e0266141.
PubMed
Abstract available
The impact of COVID-19 on music consumption and music spending.
PLoS One. 2022;17:e0267640.
PubMed
Abstract available
Addition of digital VIA/VILI to conventional naked-eye examination for triage of
HPV-positive women: A study conducted in a low-resource setting.
PLoS One. 2022;17:e0268015.
PubMed
Abstract available
Prognostic value of upper respiratory tract microbes in children presenting to
primary care with respiratory infections: A prospective cohort study.
PLoS One. 2022;17:e0268131.
PubMed
Abstract available
Nurses' experience of using video consultation in a digital care setting and its
impact on their workflow and communication.
PLoS One. 2022;17:e0264876.
PubMed
Abstract available
Development, implementation and evaluation of the online Movement, Interaction
and Nutrition for Greater Lifestyles in the Elderly (MINGLE) program: The
protocol for a pilot trial.
PLoS One. 2022;17:e0267581.
PubMed
Abstract available
It's Time to be disgusting about COVID-19: Effect of disgust priming on COVID-19
public health compliance among liberals and conservatives.
PLoS One. 2022;17:e0267735.
PubMed
Abstract available
ROX index and SpO2/FiO2 ratio for predicting high-flow nasal cannula failure in
hypoxemic COVID-19 patients: A multicenter retrospective study.
PLoS One. 2022;17:e0268431.
PubMed
Abstract available
Establishing a framework towards monitoring HCV microelimination among men who
have sex with men living with HIV in Germany: A modeling analysis.
PLoS One. 2022;17:e0267853.
PubMed
Abstract available
Exposure factors associated with SARS-CoV-2 seroprevalence during the first eight
months of the COVID-19 pandemic in the Netherlands: A cross-sectional study.
PLoS One. 2022;17:e0268057.
PubMed
Abstract available
Factors associated with change in adherence to COVID-19 personal protection
measures in the Metropolitan Region, Chile.
PLoS One. 2022;17:e0267413.
PubMed
Abstract available
Inequalities in COVID-19 inequalities research: Who had the capacity to respond?
PLoS One. 2022;17:e0266132.
PubMed
Abstract available
Prevalence and epidemiological characteristics of COVID-19 after one year of
pandemic in Jakarta and neighbouring areas, Indonesia: A single center study.
PLoS One. 2022;17:e0268241.
PubMed
Abstract available
COVID-19 vaccination readiness among multiple racial and ethnic groups in the San
Francisco Bay Area: A qualitative analysis.
PLoS One. 2022;17:e0266397.
PubMed
Abstract available
SARS-CoV-2 RT-qPCR testing of pooled saliva samples: A case study of 824
asymptomatic individuals and a questionnaire survey in Japan.
PLoS One. 2022;17:e0263700.
PubMed
Abstract available
COVID-19 vaccination in Nigeria: A rapid review of vaccine acceptance rate and
the associated factors.
PLoS One. 2022;17:e0267691.
PubMed
Abstract available
Multicenter international assessment of a SARS-CoV-2 RT-LAMP test for point of
care clinical application.
PLoS One. 2022;17:e0268340.
PubMed
Abstract available
Impact of quarantine due to COVID-19 pandemic on health and lifestyle conditions
in older adults from Centro American countries.
PLoS One. 2022;17:e0264087.
PubMed
Abstract available
Factors influencing the delivery of telerehabilitation for stroke: A systematic
review.
PLoS One. 2022;17:e0265828.
PubMed
Abstract available
Point of Care Lung Ultrasound Injury Score-A simple and reliable assessment tool
in COVID-19 patients (PLIS I): A retrospective study.
PLoS One. 2022;17:e0267506.
PubMed
Abstract available
Factors associated with prevention practices against COVID-19 in the Peruvian
population: Disparities between rural and urban areas.
PLoS One. 2022;17:e0267625.
PubMed
Abstract available
Factors influencing low-income households' food insecurity in Bangladesh during
the COVID-19 lockdown.
PLoS One. 2022;17:e0267488.
PubMed
Abstract available
Associations of vaccine status with characteristics and outcomes of hospitalized
severe COVID-19 patients in the booster era.
PLoS One. 2022;17:e0268050.
PubMed
Abstract available
Wealth, health, and beyond: Is COVID-19 less likely to spread in rich
neighborhoods?
PLoS One. 2022;17:e0267487.
PubMed
Abstract available
Effective interventions to ensure MCH (Maternal and Child Health) services during
pandemic related health emergencies (Zika, Ebola, and COVID-19): A systematic
review.
PLoS One. 2022;17:e0268106.
PubMed
Abstract available
Application of the protection motivation theory to understand determinants of
compliance with the measure of banning gathering size >4 in all public areas for
controlling COVID-19 in a Hong Kong Chinese adult general population.
PLoS One. 2022;17:e0268336.
PubMed
Abstract available
Field evaluation of the performance of seven Antigen Rapid diagnostic tests for
the diagnosis of SARs-CoV-2 virus infection in Uganda.
PLoS One. 2022;17:e0265334.
PubMed
Abstract available
SARS-CoV-2 variants of concern Alpha and Delta show increased viral load in
saliva.
PLoS One. 2022;17:e0267750.
PubMed
Abstract available
Influenza chimeric hemagglutinin structures in complex with broadly protective
antibodies to the stem and trimer interface.
Proc Natl Acad Sci U S A. 2022;119:e2200821119.
PubMed
Abstract available
How local partisan context conditions prosocial behaviors: Mask wearing during
COVID-19.
Proc Natl Acad Sci U S A. 2022;119:e2116311119.
PubMed
Abstract available
Impact of natural selection on global patterns of genetic variation and
association with clinical phenotypes at genes involved in SARS-CoV-2 infection.
Proc Natl Acad Sci U S A. 2022;119:e2123000119.
PubMed
Abstract available
The risk of COVID-19 death is much greater and age dependent with type I IFN
autoantibodies.
Proc Natl Acad Sci U S A. 2022;119:e2200413119.
PubMed
Abstract available
Vaccine-induced systemic and mucosal T cell immunity to SARS-CoV-2 viral
variants.
Proc Natl Acad Sci U S A. 2022;119:e2118312119.
PubMed
Abstract available
Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human
monoclonal antibody.
Proc Natl Acad Sci U S A. 2022;119:e2120976119.
PubMed
Abstract available
National safety surveillance of quadrivalent recombinant influenza vaccine in
Taiwan during NH 20/21.
Vaccine. 2022 May 13. pii: S0264-410X(22)00588.
PubMed
Abstract available
Effectiveness of the influenza vaccine at reducing adverse events in patients
with heart failure: A systematic review and meta-analysis.
Vaccine. 2022 May 10. pii: S0264-410X(22)00468.
PubMed
Abstract available
Background incidence rates of adverse events of special interest related to
COVID-19 vaccines in Ontario, Canada, 2015 to 2020, to inform COVID-19 vaccine
safety surveillance.
Vaccine. 2022 Apr 27. pii: S0264-410X(22)00520.
PubMed
Abstract available
Acceptance and application of a broad population health perspective when
evaluating vaccine.
Vaccine. 2022 May 4. pii: S0264-410X(22)00425.
PubMed
Abstract available
Immunogenicity and reactogenicity after booster dose with AZD1222 via intradermal
route among adult who had received CoronaVac.
Vaccine. 2022 May 2. pii: S0264-410X(22)00521.
PubMed
Abstract available
Differences in clinical outcomes of COVID-19 among vaccinated and unvaccinated
kidney transplant recipients.
Vaccine. 2022 Apr 27. pii: S0264-410X(22)00519.
PubMed
Abstract available
Safety and immunogenicity of NVX-CoV2373 (TAK-019) vaccine in healthy Japanese
adults: Interim report of a phase I/II randomized controlled trial.
Vaccine. 2022 Apr 29. pii: S0264-410X(22)00463.
PubMed
Abstract available
Post-authorization surveillance of adverse events following COVID-19 vaccines in
pregnant persons in the vaccine adverse event reporting system (VAERS), December
2020 - October 2021.
Vaccine. 2022 Apr 12. pii: S0264-410X(22)00447.
PubMed
Abstract available
Predictors of hospitalisation and death due to SARS-CoV-2 infection in Finland: A
population-based register study with implications to vaccinations.
Vaccine. 2022 Apr 22. pii: S0264-410X(22)00495.
PubMed
Abstract available
Commentary: "The vaccine Selfie" and its influence on COVID-19 vaccine
acceptance.
Vaccine. 2022 Apr 26. pii: S0264-410X(22)00503.
PubMed
De-escalation of asymptomatic testing and potential of future COVID-19 outbreaks
in US nursing homes amidst rising community vaccination coverage: A modeling
study.
Vaccine. 2022 Apr 18. pii: S0264-410X(22)00467.
PubMed
Abstract available
COVID-19 vaccinations in Bhutan - Mix-and-Match to Boosters: An experience.
Vaccine. 2022 Apr 22. pii: S0264-410X(22)00499.
PubMed
Abstract available
Strategies to improve vaccination rates in people who are homeless: A systematic
review.
Vaccine. 2022 Apr 25. pii: S0264-410X(22)00436.
PubMed
Abstract available
SARS-CoV-2 immunogenicity: Is S protein the best target for vaccination?
Vaccine. 2022 Apr 22. pii: S0264-410X(22)00501.
PubMed
Self-reported COVID-19 vaccination acceptance and hesitancy among autistic
adults.
Vaccine. 2022 Apr 22. pii: S0264-410X(22)00500.
PubMed
Abstract available
General vaccination willingness and current vaccination status in relation to
clinical and psychological variables in patients with multiple sclerosis.
Vaccine. 2022 Apr 23. pii: S0264-410X(22)00428.
PubMed
Abstract available
Covax-19/Spikogen(R) vaccine based on recombinant spike protein extracellular
domain with Advax-CpG55.2 adjuvant provides single dose protection against
SARS-CoV-2 infection in hamsters.
Vaccine. 2022 Apr 18. pii: S0264-410X(22)00469.
PubMed
Abstract available
Immunogenicity of heterologous inactivated and adenoviral-vectored COVID-19
vaccine: Real-world data.
Vaccine. 2022 Apr 18. pii: S0264-410X(22)00471.
PubMed
Abstract available
Delay between COVID-19 complete vaccination and SARS-CoV-2 infection among
healthcare workers.
Vaccine. 2022 Apr 18. pii: S0264-410X(22)00473.
PubMed
Abstract available
Impact of COVID-19 vaccine-associated side effects on health care worker
absenteeism and future booster vaccination.
Vaccine. 2022 Apr 18. pii: S0264-410X(22)00474.
PubMed
Abstract available
Increased delta variant SARS-CoV-2 infections in a highly vaccinated medical
center in Japan.
Vaccine. 2022 Apr 12. pii: S0264-410X(22)00445.
PubMed
Abstract available
Changes in incidence rates of outcomes of interest in vaccine safety studies
during the COVID-19 pandemic.
Vaccine. 2022 Apr 18. pii: S0264-410X(22)00464.
PubMed
Abstract available
Effectiveness of Covishield vaccine in preventing Covid-19 - A test-negative
case-control study.
Vaccine. 2022 Feb 9. pii: S0264-410X(22)00138.
PubMed
Abstract available
Flavonols and dihydroflavonols inhibit the main protease activity of SARS-CoV-2
and the replication of human coronavirus 229E.
Virology. 2022;571:21-33.
PubMed
Abstract available
Generation and characterization of monoclonal antibodies against the
hemagglutinin of H3N2 influenza A viruses.
Virus Res. 2022 May 17:198815. doi: 10.1016/j.virusres.2022.198815.
PubMed
Abstract available
Optimization of A(H1N1)pdm09 vaccine seed viruses: the source of PB1 and HA vRNA
as a major determinant for antigen yield.
Virus Res. 2022 Apr 30:198795. doi: 10.1016/j.virusres.2022.198795.
PubMed
Abstract available
SARS-CoV-2 epidemic in Brazil: how the displacement of variants has driven
distinct epidemic waves.
Virus Res. 2022;315:198785.
PubMed
Abstract available
Anurans against SARS-CoV-2: A review of the potential antiviral action of anurans
cutaneous peptides.
Virus Res. 2022;315:198769.
PubMed
Abstract available
Comparative analysis of SARS-CoV-2 quasispecies in the upper and lower
respiratory tract shows an ongoing evolution in the spike cleavage site.
Virus Res. 2022;315:198786.
PubMed
Abstract available
A novel plant lectin, NTL-125, interferes with SARS-CoV-2 interaction with hACE2.
Virus Res. 2022;315:198768.
PubMed
Abstract available
Mutational cascade of SARS-CoV-2 leading to evolution and emergence of omicron
variant.
Virus Res. 2022;315:198765.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by